← Leaderboards
Cyrus V Desouza
Omaha Va Medical Center
$1,331,248
Attributed
$10,649,986
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.3M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,649,986 · 1
VA$0 · 2
By mechanism
OT2$10,649,986 · 1
I01$0 · 2
Top collaborators
- Saraswathi Viswanathan5 shared
- Alejandro Pierre Comellas3 shared
- K Allen Greiner3 shared
- Akinlolu O Ojo3 shared
- Tammy Peterman3 shared
- Matthias A Salathe3 shared
- Steven W Stites3 shared
- Richelle J Koopman2 shared
Others in their field
Top investigators on “Obesity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S. Currier · University Of California Los Angeles$139,907,800
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- Peter Gordon Gillespie · Oregon Health And Science University$104,808,120
- Joseph E Robertson · Oregon Health & Science University$93,739,249
Research focus
ObesityMissionInsulin ResistanceVeteransCollaborationsGeneral PopulationLinkTargeted TreatmentHealth SystemBranched-Chain Amino AcidsClinical ResearchCorrelation StudiesAdipocytesBody WeightDesignCell LineAnti-Inflammatory AgentsAffectCellsArachidonic AcidsBlood Glucose RegulationCatabolismBindingAbdomen
Grant awards (11)
All of Us Research Program Heartland Consortium (AoURP-HC)$1,500,000
OT2 · FY2025 · OD
TP-R: a novel mediator of obesity-linked insulin resistance in humans$0
I01 · FY2025 · VA
All of Us Research Program Heartland Consortium (AoURP-HC)$2,800,000
OT2 · FY2024 · OD
TP-R: a novel mediator of obesity-linked insulin resistance in humans$0
I01 · FY2024 · VA
All of Us Research Program Heartland Consortium (AoURP-HC)$6,349,986
OT2 · FY2023 · OD
TP-R: a novel mediator of obesity-linked insulin resistance in humans$0
I01 · FY2023 · VA
TP-R: a novel mediator of obesity-linked insulin resistance in humans$0
I01 · FY2022 · VA
TP-R: a novel mediator of obesity-linked insulin resistance in humans$0
I01 · FY2021 · VA
The Role of Apathy in Glycemic Control$0
I01 · FY2011 · VA · contact PI
The Role of Apathy in Glycemic Control$0
I01 · FY2011 · VA · contact PI
The Role of Apathy in Glycemic Control$0
I01 · FY2009 · VA · contact PI